Cargando…
The Mount Sinai Prebiopsy Risk Calculator for Predicting any Prostate Cancer and Clinically Significant Prostate Cancer: Development of a Risk Predictive Tool and Validation with Advanced Neural Networking, Prostate Magnetic Resonance Imaging Outcome Database, and European Randomized Study of Screening for Prostate Cancer Risk Calculator
BACKGROUND: The European Association of Urology guidelines recommend the use of imaging, biomarkers, and risk calculators in men at risk of prostate cancer. Risk predictive calculators that combine multiparametric magnetic resonance imaging with prebiopsy variables aid as an individualized decision-...
Autores principales: | Parekh, Sneha, Ratnani, Parita, Falagario, Ugo, Lundon, Dara, Kewlani, Deepshikha, Nasri, Jordan, Dovey, Zach, Stroumbakis, Dimitrios, Ranti, Daniel, Grauer, Ralph, Sobotka, Stanislaw, Pedraza, Adriana, Wagaskar, Vinayak, Mistry, Lajja, Jambor, Ivan, Lantz, Anna, Ettala, Otto, Stabile, Armando, Taimen, Pekka, Aronen, Hannu J., Knaapila, Juha, Perez, Ileana Montoya, Gandaglia, Giorgio, Martini, Alberto, Picker, Wolfgang, Haug, Erik, Cormio, Luigi, Nordström, Tobias, Briganti, Alberto, Boström, Peter J., Carrieri, Giuseppe, Haines, Kenneth, Gorin, Michael A., Wiklund, Peter, Menon, Mani, Tewari, Ash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9257660/ https://www.ncbi.nlm.nih.gov/pubmed/35813258 http://dx.doi.org/10.1016/j.euros.2022.04.017 |
Ejemplares similares
-
Unified model involving genomics, magnetic resonance imaging and prostate‐specific antigen density outperforms individual co‐variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancer
por: Beksac, Alp Tuna, et al.
Publicado: (2021) -
Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
por: Chakravarty, Dimple, et al.
Publicado: (2020) -
A 4K score/MRI‐based nomogram for predicting prostate cancer, clinically significant prostate cancer, and unfavorable prostate cancer
por: Wagaskar, Vinayak G., et al.
Publicado: (2021) -
Added value of systematic biopsy in men with a clinical suspicion of prostate cancer undergoing biparametric MRI-targeted biopsy: multi-institutional external validation study
por: Falagario, Ugo, et al.
Publicado: (2020) -
Clash of the calculators: External validation of prostate cancer risk calculators in men undergoing mpMRI and transperineal biopsy
por: Wei, G., et al.
Publicado: (2021)